Skandinaviska Enskilda Banken AB »

Catalyst Pharmaceutical Partners shares owned by Skandinaviska Enskilda Banken AB

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Skandinaviska Enskilda Banken AB from 13F filings

Historical chart of Skandinaviska Enskilda Banken AB investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Skandinaviska Enskilda Banken AB

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.3M 420k 19.88

More positions owned by Skandinaviska Enskilda Banken AB

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Abbvie (ABBV)
Merck & Co (MRK)
Tesla Motors (TSLA)

View all positions for Skandinaviska Enskilda Banken AB

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Henderson Group
Royce & Associates
Northern Trust
Kennedy Capital Management
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners